Overview

Study to Determine How BCX4161 is Metabolized and Eliminated by the Body

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the extent that radioactive dose of BCX4161 taken by mouth ends up in the urine, feces and expired air. If there are metabolites of BCX4161 made by the body, the chemical composition of these metabolites and their profile over time in blood and urine will be determined.
Phase:
Phase 1
Details
Lead Sponsor:
BioCryst Pharmaceuticals